Effect of sarilumab on unacceptable pain and inflammation control in Japanese patients with moderately-to-severely active rheumatoid arthritis: <i>Post hoc</i> analysis of a Phase III study (KAKEHASI)Yoshiya Tanaka, Hideto Kameda, Hubert van Hoogstraten et al.|Modern Rheumatology|2023Cited by 5
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumabYoshiya Tanaka, Hideto Kameda, Toshiya Takahashi et al.|Clinical and Experimental Rheumatology|2021Cited by 2